The FDA study section reported a favorable review for the antiplatelet drug cangrelor developed by The Medicines Company, New Jersey. Read the committee report here. Cangrelor now awaits full FDA approval.
George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.